Oversea-Chinese Banking Corp (OCBC)’s Moderna MRNA Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,069	Closed	-$296K	–	365
2025 Q3	$296K	Sell	12,069 -37,172	-75%	-$1.04M	0.01%	302
2025 Q2	$1.36M	Buy	49,241 +8,469	+21%	+$223K	0.04%	187
2025 Q1	$1.31M	Buy	40,772 +17,268	+73%	+$613K	0.04%	206
2024 Q4	$943K	Sell	23,504 -5,341	-19%	-$255K	0.03%	227
2024 Q3	$1.84M	Buy	28,845 +26,488	+1,124%	+$2.43M	0.05%	185
2024 Q2	$280K	Sell	2,357 -2,387	-50%	-$302K	0.01%	332
2024 Q1	$506K	Buy	+4,744	New	+$478K	0.02%	288
2023 Q4	–	Sell	-2,625	Closed	-$271K	–	372
2023 Q3	$271K	Sell	2,625 -12,488	-83%	-$1.39M	0.01%	332
2023 Q2	$1.84M	Buy	15,113 +12,150	+410%	+$1.62M	0.09%	151
2023 Q1	$437K	Buy	+2,963	New	+$489K	0.02%	236

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s MRNA Position: Q4 2025 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Moderna (MRNA) in Q4 2025, closing a stake of 12,069 shares — an estimated $296K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in MRNA in Q1 2023 and held it in 10 quarters. The position peaked at $1.84M in Q3 2024. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

Oversea-Chinese Banking Corp (OCBC) reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
Oversea-Chinese Banking Corp (OCBC) sold 12,069 Moderna shares in Q4 2025, an estimated $296K.
Oversea-Chinese Banking Corp (OCBC) first reported a position in Moderna in Q1 2023 and held it in 10 quarters.
Oversea-Chinese Banking Corp (OCBC)'s Moderna position peaked at $1.84M in Q3 2024.
673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q4 2025, filed 28 Jan 2026.